2 cryptocurrencies that might be worth your investment this week
The crypto sector seems to be recovering from the price drop following the FOMC meeting where the Federal Reserve decided to leave the benchmark interest rate unchanged.
During the recovery, two cryptocurrencies reported good performance. These are Injective (INJ) and Oasis (ROSE).
Injectable (INJ)
Injectable (INJ) signals for a very strong buy judging by the performance of the asset.
The 24-hour RSI is at 64.17, which is an indication that a price spike can be expected. The 11% price increase in the last 24 hours also demonstrates confidence.
By all accounts, buyers seem to be quite bullish and only time and more investors can push the cryptocurrency even higher. At the time of writing, INJ is trading at $31.04.
Oasis (ROSE)
Oasis (ROSE) too demonstrable the highly positive attitude of people who are ready to take the strong technical signals observed in the market by executing buy orders.
The 24-hour RSI is at 68.61, suggesting good buying power. The price recorded a growth of over 6%, which is the result of the stable confidence of the market. At the time of writing, ROSE is trading at $0.1299
The current buying pressure is a clear sign that this altcoin could prove to be a good option for traders and investors looking for potential opportunities this week.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Alphabet (GOOGL.US) reportedly plans to issue its first Hong Kong dollar and Singapore dollar bonds, potentially testing investor confidence amid growing concerns over AI financing.
Alphabet has recently held discussions about the potential issuance of its first Hong Kong dollar and Singapore dollar bonds. Amid global market volatility caused by sell-offs in artificial intelligence (AI) related sectors, this deal will test Asian investors’ appetite for subscription.

The "Blue Wave" overturns chip stocks, Morgan Stanley remains bullish on Seagate (STX.US): Weak market sentiment diverges from fundamentals, listed as the top storage pick
Morgan Stanley maintains an "Overweight" rating on Seagate Technology with a target price of $1,148.

Chart - AI Stock Plunge Triggers Market Alert. Here’s What Traders Are Watching

Earnings Preview | Rocket Lab (RKLB.US) Faces Ongoing Profit Pressure Amid Revenue Surge, Neutron Delay Concerns Gradually Disappear
The market currently anticipates that Rocket Lab's revenue in the third quarter will increase by nearly 66% year-on-year to $257 million, with a GAAP net loss of $0.08 per share.